Established in 1956, Leo Lynch provides a full range of construction engineering services to the life sciences (biotechnology, primary and secondary pharmaceutical), medical technology, food, microelectronics, healthcare, educational, commercial and public sectors.
Total Turnover:
€50m
ROI Turnover:
€50m
Leo Lynch Projects
The company was involved in some high profile and exciting projects during 2020. These included the completion of a significant plant expansion for Pfizer Newbridge and the start of a very high-profile brownfield project for a confidential client.
“Existing, repeat-business clients are a mainstay of the business and are truly valued,” says Ciaran O’Donnell, Business Development Director, Leo Lynch.
Long-term clients include Pfizer, Abbott, BMS, SK biotek, Diageo, Takeda, Glanbia, Analog Devices, Tyndall National Institute, IPUT and Kennedy Wilson.
Integrated Management System
The engineering contractor takes a proactive approach to health and safety. The company’s integrated management system interlinks the ISO 9001:2015 accredited quality system with its Safe-T-Cert accredited health and safety system and its ISO 14001:2015 accredited environmental management system.
Rigorous implementation of its IMS has shown significant benefits and savings in project execution, which are passed on to clients. It also uses lean practices and BIM as part of its IMS.
No 12: Leo Lynch Group
ADDRESS: 16 Fonthill Industrial Park, Clondalkin, Dublin 22.
PHONE: 01 626 1144
WEB: www.leolynch.com
LINKEDIN: Leo Lynch
KEY EXECUTIVES: Sean Smith, Group Managing Director; Conor Lynch, Group Commercial Director; Brian Sterling, Director; Ciaran O’Donnell, Business Development Director.
KEY ACTIVITIES: Mechanical, Process and Electrical Engineering Services.
YEAR END: 31/12/2020